Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIMM44 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GRB14 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC6A13 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PGK1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SSTR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CDX1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GFI1B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BNIP3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HMGN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BTN3A2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARHGAP25 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HSPA12A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LZTR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC22A7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GPR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GNPTAB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPL36 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCXR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARMC9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SNORD54 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on